Literature DB >> 24841076

Medical thoracoscopy: rigid thoracoscopy or flexi-rigid pleuroscopy?

Kim Hoong Yap1, Martin J Phillips, Y C Gary Lee.   

Abstract

PURPOSE OF REVIEW: In managing pleural diseases, medical thoracoscopy is often performed as a diagnostic and/or therapeutic procedure, particularly in undiagnosed pleural effusions. Flexi-rigid pleuroscopes are now widely available as an alternative to conventional rigid thoracoscopes. There is an ongoing debate on which is the better instrument. This review analyses the current literature that compared rigid and flexi-rigid approaches, and outlines the medical advances that may influence the future role of thoracoscopy. RECENT
FINDINGS: Both rigid and flexi-rigid thoracoscopies are well tolerated. Although biopsies are smaller with flexi-rigid biopsy forceps, two small randomized trials reported similar diagnostic yield using either instrument. No studies have specifically examined patient comfort or the outcome of talc poudrage using the two devices. New techniques (e.g. insulated-tip knife and cryobiopsy) have been used as adjuncts with flexi-rigid pleuroscopy to overcome the difficulties in sampling thickened pleura.
SUMMARY: The rigid and flex-rigid instruments have different merits and limitations. Both approaches provide comparable diagnostic yields in the overall patient population undergoing diagnostic thoracoscopy, though their performances specifically in patients with fibrotic pleural thickening have not been examined. Operators using the flexi-rigid approach should have alternative strategies for sampling thickened pleura. Advances in cytopathology and imaging-guided biopsy will likely reduce the need of medical thoracoscopy in the future.

Entities:  

Mesh:

Year:  2014        PMID: 24841076     DOI: 10.1097/MCP.0000000000000059

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  7 in total

1.  Initial experience of medical pleuroscopy via the peel-away introducer of the indwelling pleural catheter using a thin bronchoscope.

Authors:  Kassem Harris; Abdul Hamid Alraiyes; Samjot Singh Dhillon
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

Review 2.  Interventional pulmonologist perspective: treatment of malignant pleural effusion.

Authors:  Andrew J Sweatt; Arthur Sung
Journal:  Curr Treat Options Oncol       Date:  2014-12

3.  Biopsy and rebiopsy for non-small-cell lung cancer: current and future methods.

Authors:  Paul Zarogoulidis; Christoforos Kosmidis; Varvara Fyntanidou; Zoi Aidoni; Kosmas Tsakiridis; Charilaos Koulouris; Nikolaos Michalopoulos; Anastasios Barmpas; Haidong Huang; Chong Bai; Wolfgang Hohenforst-Schmidt; Konstantinos Sapalidis
Journal:  Lung Cancer Manag       Date:  2019-10-17

Review 4.  Malignant Pleural Effusion: Diagnosis and Management.

Authors:  Lucía Ferreiro; Juan Suárez-Antelo; José Manuel Álvarez-Dobaño; María E Toubes; Vanessa Riveiro; Luis Valdés
Journal:  Can Respir J       Date:  2020-09-23       Impact factor: 2.409

5.  Comparing the diagnostic accuracy of semi-rigid and rigid pleuroscopy in diagnosis of exudative lymphocyte dominant pleural effusion with.

Authors:  Hamid Borsi; Mohammad Reza Farahnak; Hanieh Raji; Maryam Haddadzadeh Shooshtari; Behnam Pirhayati
Journal:  J Family Med Prim Care       Date:  2020-10-30

6.  Role of medical thoracoscopy in the treatment of complicated parapneumonic effusions.

Authors:  Ramanjaneya Ranganatha; Syed Zulkharnain Tousheed; Bangalore Venkatraman MuraliMohan; Muhammed Zuhaib; Deepika Manivannan; B R Harish; Poojaramuddanahally Hanumantharayappa Manjunath; Kedar R Hibare; Hemanth Kumar; Chandrasekar Sagar; Vellaichamy Muthupandi Annapandian
Journal:  Lung India       Date:  2021 Mar-Apr

7.  Factors associated with discrepancy between fresh frozen and permanent biopsy from medical thoracoscopy: single center analysis of 172 medical flexible thoracoscopy cases.

Authors:  Jeong Uk Lim; Jongyeol Oh; Hyung Woo Kim; Woo Ho Ban; Eun Su Park; Jick Hwan Ha; Ju Sang Kim; Sang Haak Lee
Journal:  J Thorac Dis       Date:  2020-12       Impact factor: 2.895

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.